News

Erwinase® gains Marketing Approval in Japan

erwinase

Porton Biopharma Limited has been working to support Ohara Pharmaceutical Co. Ltd. who have today announced that they have obtained marketing approval for Erwinase® from the Ministry of Health Labour and Welfare in Japan.

read more

New Finance Director Joins PBL

Amir Malik

PBL have appointed Amir Malik as finance director to assist with strategic planning and direction.  Amir has almost 20 years experience in a range of strategic finance roles, is a qualified chartered accountant, has an MBA in finance and  a BSc in Chemistry, and brings a wealth of experience of working in both the public and private sectors

read more

Porton Biopharma investing in staff

PBL staff with MD Dr Roger Hinton and their certificates

Our latest cohort of staff have been independently assessed and achieved a whole series of level 2 and 3 NVQ awards, the awards are in subjects including storage & warehousing and laboratory skills.

read more

Porton Biopharma appoints new Non Executive Director

Nigel Brooksby

We are pleased to announce that we have appointed Nigel Brooksby as a new Non Executive Director to the PBL Board.  Nigel will take up his position from June and brings to the Board his considerable knowledge and experience in biopharmaceuticals and life-sciences.

read more

Construction starts on new fermentation facility at PBL

MP John Glen breaks ground on the new facility

In a “ground breaking ceremony” led by MP for Salisbury John Glen, Porton Biopharma Ltd (PBL) has initiated the construction of a new multi-million pound facility. The investment will see the creation of a pharmaceutical process facility that contains a new large state-of-the-art fermenter, process train and associated utilities.

read more

PBL celebrates its first year

fist year

PBL has enjoyed considerable success during its first year of operation by meeting all of our milestones and by investing in both staff and facilities.

read more